Hormonal evaluation and midcycle detection of intrauterine glycodelin in women treated with levonorgestrel as in emergency contraception

Contraception

Volumn 82, Issue 6, 2010, Pages 526-533

  Durand, Marta ^a,b   Koistinen, Riitta ^c   Chirinos, Mayel ^a   Rodríguez, José Luis ^a   Zambrano, Elena ^a   Seppälä, Markku ^c   Larrea, Fernando ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Glycodelin; Hormonal emergency contraception; Levonorgestrel; Mechanism of action

Indexed keywords

ESTRADIOL; ESTRONE; LEVONORGESTREL; LUTEINIZING HORMONE; PLACENTA PROTEIN 14; PROGESTERONE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EMERGENCY CONTRACEPTION; FEMALE; FERTILIZATION; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; LUTEAL PHASE; NORMAL HUMAN; OVARY CYCLE; OVARY FOLLICLE DEVELOPMENT; OVULATION;

ADULT; CONTRACEPTION, POSTCOITAL; CONTRACEPTIVE AGENTS, FEMALE; ENDOMETRIUM; ESTRADIOL; ESTRONE; FEMALE; GLYCOPROTEINS; GONADAL STEROID HORMONES; HUMANS; LEVONORGESTREL; LUTEAL PHASE; LUTEINIZING HORMONE; MENSTRUAL CYCLE; OVARIAN FOLLICLE; OVULATION; PREGNANCY PROTEINS; PROGESTERONE; UTERUS; YOUNG ADULT;

EID: 78249288750     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.05.015     Document Type: Article

References (22)

1. Trussell J., and Stewart F. The effectiveness of postcoital hormonal contraception Fam Plann Perspect 24 1992 262 264
2. World Health Organization Task Force on Postovulatory Methods of Fertility Regulation. Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined contraceptives for emergency contraception Lancet 352 1998 428 433
3. Durand M., del Carmen Cravioto M., and Raymond E.G. On the mechanisms of action of short-term levonorgestrel administration in emergency contraception Contraception 64 2001 227 234
4. Croxatto H.B., Brache V., and Pavez M. Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation Contraception 70 2004 442 450
5. Wilcox A.J., Weinberg C.R., and Baird D.D. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby N Engl J Med 333 1995 1517 1521
6. von Hertzen H., Piaggio G., and Ding J. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial Lancet 360 2002 1803 1810
7. Durand M., Seppala M., and Cravioto M del C. Late follicular phase administration of levonorgestrel as an emergency contraceptive changes the secretory pattern of glycodelin in serum and endometrium during the luteal phase of the menstrual cycle Contraception 71 2005 451 457
8. Oehninger S., Coddington C.C., Hodgen G.D., and Seppala M. Factors affecting fertilization: endometrial placental protein 14 reduces the capacity of human spermatozoa to bind to the human zona pellucida Fertil Steril 63 1995 377 383
9. Batzer F.R. Ultrasonic indices of ovulation J Reprod Med 31 Suppl 1986 764 769
10. Miller P.B., and Soules M.R. The usefulness of a urinary LH kit for ovulation prediction during menstrual cycles of normal women Obstet Gynecol 87 1996 13 17
11. Larrea F., Sandoval J.L., Salinas E., Franco-Rodriguez V.A., Mendez I., and Ulloa-Aguirre A. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia Clin Endocrinol 43 1995 591 600
12. Koistinen H., Koistinen R., and Dell A. Glycodelin from seminal plasma is a differentially glycosylated form of contraceptive glycodelin-A Mol Hum Reprod 2 1996 759 765
13. Croxatto H.B., Fuentealba B., and Brache V. Effects of the Yuzpe regimen, given during the follicular phase, on ovarian function Contraception 65 2002 121 128
14. 2 Mol Endocrinol 15 2001 2093 2105
15. Verpoest V.M.J.A., Cahill D.J., Harlow C.R., and Hull M.G.R. Relationship between midcycle luteinizing hormone surge quality and oocyte fertilization Fertil Steril 73 2000 75 77
16. Durand M., Larrea F., and Schiavon R. Mechanisms of action of emergency contraception: pre- and post-fertilization effects of levonorgestrel Salud Publica Mex 51 2009 255 261
17. Lalitkumar P.G., Lalitkumar S., and Meng C.X. Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model Hum Reprod 22 2007 3031 3037
18. Mandelin E., Koistinen H., Koistinen R., Affandi B., and Seppälä M. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism? Hum Reprod 12 1997 2671 2675
19. Mandelin E., Koistinen H., Koistinen R., Arola J., Affandi B., and Seppälä M. Endometrial expression of glycodelin in women with levonorgestrel-releasing subdermal implants Fertil Steril 76 2001 474 478
20. Seppälä M., Koistinen H., Koistinen R., Chiu P.C.N., and Yeung W.S.B. Glycosylation related actions of glycodelin: gamete, cumulus cell, immune cell and clinical associations Hum Reprod Update 13 2007 275 287
21. Seppälä M., Taylor R.N., Koistinen H., Koistinen R., and Milgrom E. Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation Endocr Rev 23 2002 401 430
22. Chiu P.C.N., Chung M.K., and Koistinen R. Cumulus oophorus-associated glycodelin-C displaces sperm-bound glycodelin-A and -F and stimulates spermatozoa-zona pellucid binding J Biol Chem 282 2007 5378 5388